Introduction {#Sec1}
============

Articular cartilage is composed of chondrocyte and extracellular matrix and has an important role in joint movement including lubrication, shock absorption and conduction. However, trauma injury and many joint diseases, such as osteoarthritis(OA) can damage the cartilage layer^[@CR1]^. Cartilage defects lead to restriction of joint activities, which results in pain and adverse effects on people's lives, especially for knee articular cartilage patients. Damaged knee cartilage does not receive a sufficient blood supply, which limits its ability to repair itself^[@CR2]^. Cartilage defect can also progress to OA at a later stage. The current treatment for cartilage defect includes physiotherapy, external medication, intra-articular injection, and intra-articular irrigation. Chondroplasty is an alternative method that can relieve pain^[@CR3]^. However, these treatments have not been found to regenerate new cartilage-like tissue and cartilage defects can progress and develop into more severe cartilage damage^[@CR4],[@CR5]^. Tissue engineering strategies combining cells and a scaffold are used to achieve cartilage regeneration^[@CR6]^.

In recent years, cell therapy has been used to treat cartilage damage. Mesenchymal stem cells (MSCs) have been suggested as a potential cell fortreatment of OA because of their multiple differentiative capacity to produce cells via osteogenesis, adipogenesis, and chondrogenesis^[@CR7]--[@CR10]^. MSCs are used in many cell-based tissue engineering application and have been confirmed to be safe and feasible for treatment in human beings. In addition, MSCs have been found to improve clinical symptoms such as pain, disability, and physical function^[@CR11]--[@CR13]^. Autologous MSCs are proper sources of cells, but to obtain them requires that patients undergo an additional operation. Allogeneic bone marrow mesenchymal stem cells (BMSCs) have been used to treat cartilage defects and to promote neocartilage formation in some studies^[@CR14],[@CR15]^. Hyaluronic acid (HA) is an important component of synovial fluid that protects joint cartilage by lubricating and absorbing shock^[@CR16]^. HA maintains a constant concentration and sufficient viscosity in the knee joint. When OA occurs, the concentration of HA decreases, which aggravates damage to knee cartilage^[@CR17],[@CR18]^. Additionally, HA can also promote cell migration^[@CR19],[@CR20]^ and is suggested to be injected every 3 months for knee joint disease^[@CR21]^. Many clinical studies also have reported that HA could relieve the pain of OA patients^[@CR22]--[@CR24]^.

In this study, we obtained BMSCs by performing a standard isolation and culture procedure. After inducing cartilage defects in canines, the therapeutic effects of injections of BMSCs plus HA, HA alone, and normal saline were compared by assessing gross appearance, evaluating MRI results, and performing histological and immunohistochemical analysis.

Results {#Sec2}
=======

Three canines used for obtaining bone marrow were left for other studies, and the other 24 canines appeared to recover 1 week after the operation. No deaths occurred, no local infections developed, and all animals moved freely. Additionally, flow cytometry was performed and the results were shown in Figure [S1](#MOESM1){ref-type="media"}. The positive rates of CD 166, CD 29, CD 90, CD 105 and CD 44 were 100%, 99.9%, 100%, 93.5% and 100%, respectively, and the negative rates of CD45 and CD 34 were 99.4%, and 99.8%, respectively. The antigenic profile conformed to cellular therapy criteria of MSCs. After induction in special culture, osteogenesis and chondrogenesis of BMSCs was shown in Figure [S2](#MOESM1){ref-type="media"}. Extracellular matrix appeared light red after chondrogenesis, and calcium nodules were stained orange after osteogenesis.

Gross appearance of the cartilage {#Sec3}
---------------------------------

Varying degrees of cartilage damage were sustained 28 weeks after injection. Representative gross of cartilage was shown in Fig. [1](#Fig1){ref-type="fig"}. No significant degenerative changes were observed in knee-joint cartilage except for cartilage defects (medial condyle, intercondylar groove, and lateral condyle of femur). For group A, new cartilage-like tissue was frequently observed at 4 defect sites (Fig. [1](#Fig1){ref-type="fig"}), the surface color was relatively normal, and new cartilage-like tissue connected well with surrounding cartilage tissue. For group B, new cartilage-like tissue was also frequently observed (Fig. [1](#Fig1){ref-type="fig"}), but a small scratch was visible on the junction between the defect sites and normal sites. For group C, the cartilage defects were not covered and new cartilage-like tissue was hardly observed (Fig. [1](#Fig1){ref-type="fig"}).Figure 1The gross appearance of the cartilage 28 weeks after injection. Representative gross appearance among the group A (BMSCs plus HA), B (HA alone) and C (control group) 28 weeks after injection.

Radiological analysis {#Sec4}
---------------------

Twenty-eight weeks after injection, MRI was performed. MRI examination of regenerated new cartilage tissue was shown in Fig. [2](#Fig2){ref-type="fig"}. For group A, cartilage-like signal was observed at defect sites, and the surface of cartilage was smooth relatively. No obvious defect was found and cartilage-like tissue with the same thickness of the surrounding normal tissue was formed (Fig. [2](#Fig2){ref-type="fig"}). For group B, cartilage-like signal was also observed, but the thicknesses of tissue at the defect sites were thinner than those at normal (Fig. [2](#Fig2){ref-type="fig"}). For group C, no cartilage-like signal was observed. These data indicated that MSCs plus HA could stimulate the formation of new cartilage-like tissue better than HA alone or normal saline for cartilage defect (Fig. [2](#Fig2){ref-type="fig"}).Figure 2The MRI of the cartilage 28 weeks after injection. Representative MRI among the group A (BMSCs plus HA), B (HA alone) and C (control group) 28 weeks after injection.

Histological and immunohistochemical analysis {#Sec5}
---------------------------------------------

Hematoxylin and eosin (HE) staining, Masson staining, and toluidine blue staining were performed. Representative photomicrographs of HE staining of groups A, B and C were shown in Fig. [3](#Fig3){ref-type="fig"}. In group A, tissue similar to neocartilage covered the defect site, and chondrocytes were formed and the matrix staining was normal (Fig. [3](#Fig3){ref-type="fig"}). In group B, some tissue similar to cartilage and fibrous tissue was observed (Fig. [3](#Fig3){ref-type="fig"}). However, tissue similar to neocartilage was seldom seen at the defect sites in group C (Fig. [3](#Fig3){ref-type="fig"}).Figure 3The HE staining of the cartilage 28 weeks after injection. Representative HE staining among the group A (BMSCs plus HA), B (HA alone) and C (control group) 28 weeks after injection. The black rectangle indicated repairing sites on low magnification (X30) and would be magnified to high magnification (X100). Tro: trochlear defects. Con: condyle defects. X30 (Scale bars = 500 μm), X100 (Scale bars = 100 μm).

Representative photomicrographs of Masson staining were shown in Fig. [4](#Fig4){ref-type="fig"}. In group A, many chondrocytes were seen, tissue similar to cartilage fiber was revealed regularly, and the color of matrix was relatively normal compared with that of normal cartilage tissue (Fig. [4](#Fig4){ref-type="fig"}). For group B, chondrocytes were hardly observed, most of the cells were non-chondrocytes, and the color of matrix was paler compared to that of normal cartilage (Fig. [4](#Fig4){ref-type="fig"}). For group C, no cartilage was observed at the defect sites (Fig. [4](#Fig4){ref-type="fig"}).Figure 4The Masson staining of the cartilage 28 weeks after injection. Representative Masson staining among the group A (BMSCs plus HA), B (HA alone) and C (control group) 28 weeks after injection. The black rectangle indicated repairing sites on low magnification (X30) and would be magnified to high magnification (X100). Tro: trochlear defects. Con: condyle defects. X30 (Scale bars = 500 μm), X100 (Scale bars = 100 μm).

Representative photomicrographs of toluidine blue staining were shown in Fig. [5](#Fig5){ref-type="fig"}. Group A showed darker blue staining at defect sites with uniform cartilage cell and clear tidemark (Fig. [5](#Fig5){ref-type="fig"}). Pale blue staining, few cartilage cells, and a mass of fibrous cell and fiber tissue were observed in group B (Fig. [5](#Fig5){ref-type="fig"}). No neocartilage tissue was observed ingroup C (Fig. [5](#Fig5){ref-type="fig"}).Figure 5The Toluidine blue staining of the cartilage 28 weeks after injection. Representative Toluidine blue staining among the group A (BMSCs plus HA), B (HA alone) and C (control group) 28 weeks after injection. The black rectangle indicated repairing sites on low magnification (X30) and would be magnified to high magnification (X100). Tro: trochlear defects. Con: condyle defects. X30 (Scale bars = 500 μm), X100 (Scale bars = 100 μm).

Representative photomicrographs of the immunohistochemistry analysis of the neocartilage from all three groups were shown in Fig. [6](#Fig6){ref-type="fig"}. Group A exhibited large numbers of chondrocyte cells. The color of the defect sites in group A was relatively normal compared with that of the surrounding tissue, which indicated that much more type II collagen protein was formed (Fig. [6](#Fig6){ref-type="fig"}). In group B, few cells similar to chondrocytes were shown and the color was light at the defect sites (Fig. [6](#Fig6){ref-type="fig"}). In group C, no new tissue was formed (Fig. [6](#Fig6){ref-type="fig"}). These data indicated presence of more collagen fiber in group A than in groups B and C. The histochemical and immunohistochemical analysis suggested that BMSCs plus HA could stimulate the regeneration of cartilage better than HA alone.Figure 6The type II collagen immunohistochemistry staining of the cartilage 28 weeks after injection. Representative type II collagen staining among the group A (BMSCs plus HA), B (HA alone) and C (control group) 28 weeks after injection. The black rectangle indicated repairing sites on low magnification (X30) and would be magnified to high magnification (X100). Tro: trochlear defects. Con: condyle defects. X30 (Scale bars = 500 μm), X100 (Scale bars = 100 μm).

Gross-grading scale and histological score {#Sec6}
------------------------------------------

After two researchers assessed the treatment, macroscopic evaluation and histological assessment scoring were performed (Table [3](#Tab3){ref-type="table"}). For the trochlear defects, the International Cartilage Repair Society (ICRS) macroscopic score for group A (9.75 ± 1.984) was greater than those in group B (7.75 ± 2.449) and group C (5.91 ± 2.176), with a significant difference (*P* \< 0.001). The ICRS macroscopic score for group B was significantly superior to group C (*P* \< 0.01) (Fig. [7a](#Fig7){ref-type="fig"}). The ICRS histological score for group A (13.75 ± 4.303) was superior to those in group B (10.19 ± 4.789, *P* \< 0.001) and group C (6.44 ± 3.388, *P* \< 0.001). There was also significant difference between group B and group C (*P* \< 0.001) (Fig. [7b](#Fig7){ref-type="fig"}).Table 1ICRS macroscopic evaluation of cartilage repair.Featurescore**Degree of defect repair**In level with surrounding cartilage475% repair of defect depth350% repair of defect depth225% repair of defect depth10% repair of defect depth0**Integration to border zone**Complete integration with surrounding cartilage4Demarcating border \<1 mm33/4th of graft integrated, 1/4th with a notable border \>1 mm width21/2 of graft integrated with surrounding cartilage, 1/2 with a notable border \>1 mm1From no contact to 1/4th of graft integrated with surrounding cartilage0**Macroscopic appearance**Intact smooth surface4Fibrillated surface3Small, scattered fissures or cracs2Several, small or few but large fissures1Total degeneration of grafted area0**Overall repair assessment**Grade I: normal12Grade II: nearly normal11--8Grade III: abnormal7--4Grade IV: severely abnormal3--1This table was adopted from ref.^[@CR54]^.Table 2ICRS Visual Histological Assessment Scale.Featurescore**Surface**Smooth/continuous3Discontinuities/irregularities0**Matrix**Hyaline3Mixture: hyaline/fibrocartilage2Fibrocartilage1Fibrous tissue0**Cell distribution**Columnar3Mixed/columnar-clusters2Clusters1Individual cells/disorganized0**Cell population viability**Predominantly viable3Partially viable1\<10% viable0**Subchondral Bone**Normal3Increased remodeling2Bone necrosis/granulation tissue1Detached/fracture/callus at base0**Cartilage mineralization (calcified cartilage)**Normal3Abnormal/inappropriate location0This table was adopted from ref.^[@CR55]^.Table 3The basic characteristics of ICRS marcroscopic score and ICRS histological score.gross/HistologicalgroupNMeanSDrange95% Confidence Interval for MeanICRS marcroscopic scoreMSCs + HA trochlear329.751.9846--129.03--10.47HA trochlear327.752.4493--116.87--8.63control trochlear325.912.1762--95.12--6.69MSCs + HA condylar328.842.2163--118.04--9.64HA condylar3271.7962--116.35--7.65control condylar325.282.3991--94.42--6.15ICRS histological scoreMSCs + HA trochlear3213.754.3033--1812.20--15.30HA trochlear3210.194.7891--178.46--11.91control trochlear326.443.3883--155.22--7.66MSCs + HA condylar3212.534.1893--1811.02--14.04HA condylar329.53.7429--178.15--10.85control condylar325.253.2923--154.06--6.44Figure 7The ICRS scale for macroscopic and histological assessment 28 weeks after injection. The macroscopic and histological assessment among the group A (BMSCs plus HA), B (HA alone) and C (control group) 28 weeks after injection. Tro: trochlear defects. Con: condyle defects (\*P \< 0.05 \*\*P \< 0.01).

For the condylar defects, the ICRS macroscopic score for groups A, B and C were 8.84 ± 2.216, 7.00 ± 1.796, and 5.28 ± 2.399, respectively. Significant difference was found between groups A and B (*P = *0.001), groups B and C (P = 0.002) and groups A and C (*P* \< 0.001) (Fig. [7c](#Fig7){ref-type="fig"}). Additionally, the ICRS histological score for groups A, B and C were 12.53 ± 4.189, 9.50 ± 3.742 and 5.25 ± 3.292 respectively. The score in group A was superior to those in group B (*P = *0.003) and group C (*P* \< 0.001), and the score in group B was also superior to those in group C (*P* \< 0.001) (Fig. [7d](#Fig7){ref-type="fig"}). These results suggested that both BMSCs plus HA and HA alone were effective in promoting the formation of neocartilage in cartilage defects and that adding BMSCs could improve the therapeutic effect.

Discussion {#Sec7}
==========

In this study, we assessed the therapeutic effects of BMSCs and HA for cartilage defects in a beagle model. Our results showed that both BMSCs plus HA and HA alone could significantly promote neocartilage formation. However, BMSCs plus HA had a more prominent therapeutic effect on cartilage defects when compared to the HA alone. This therapeutic effect performed in the aspect of macroscopic analysis, MRI analysis, surface intact, osteochondral junction, matrix staining, neocartilage thickness and cell morphology.

Articular damage of cartilage defects is observed in trauma injury in people, especially athletes, and may cause pain and functional disability. The treatment of cartilage defects includes conventional treatments, physiotherapy, and surgical procedures and so on^[@CR25]^. However, the abovementioned treatments can only delay the progression of articular cartilage damage but can not solve the problem fundamentally. Cartilage engineering can promote formation of neocartilage and has been commonly used to repair whole-layer cartilage defects in recent years^[@CR26]^.

An ideal cartilage defect model is very important. In this study, 4-mm diameter acute (3 week) defects were induced successfully in canines that weighed 5--6 kg at 5--7 months old. This cartilage defect model was used in previous studies^[@CR27],[@CR28]^. In Breinan's study^[@CR27]^, 4-mm diameter cartilage defects were successfully induced in 14 canines and used for further study. Many small animals (mice or rabbits) have been more popular and used for cartilage defect models in previous studies^[@CR15],[@CR29]^. Canines are larger animals, and the biomechanics of canine's knee joint is more similar to than are those of humans compared with mice and rabbits. And the beagles used in this study were moderately sized canine and represent a transition from a small-animal to a large-animal model. In the future, large-animal models could be used for further experimentation.

MSCs are a promising way to treat cartilage defects and have been used in many studies for knee articular damage with cartilage injury^[@CR9],[@CR10],[@CR30]^. Autologous MSCs have been confirmed to provide excellent therapeutic effects in previous studies^[@CR31]--[@CR33]^. However, autologous cells are obtained from the patients themselves, which means that another invasive surgery is needed. Allogeneic BMSCs can be isolated from a variety of sources, are available for mass-production, and have a multipotent capability to produce cells via osteogenesis, adipogenesis and chondrogenesis^[@CR15]^, which was also confirmed in our study. MSCs have been found to regenerate damaged cartilage, and inhibit fibrosis and inflammation without causing obvious rejection, because they can be safely transplanted^[@CR34],[@CR35]^. The safety of immunomodulatory reactions of allogeneic MSCs *in vivo* also has been reported in Park's study^[@CR35]^. In some clinical studies^[@CR36]--[@CR38]^, MSCs have also been used without significant adverse reactions. A study by Park indicated that an allogeneic MSCs‐based novel medicinal product appeared to be safe and effective for regeneration of durable hyaline‐like cartilage over years of follow-up^[@CR39]^. Another study by Gupta also found that intra-articular administration of allogeneic MSCs was safe^[@CR40]^. Many studies also have found that BMSCs could promote cartilage repair and inhibit cartilage damage progression through a trophic mechanism via secreting cytokines^[@CR14],[@CR30]^. In the present study, neocartilage-like cells were also observed in the defect sites 28 weeks after operation.

The quantity and quality of HA in synovial fluid are changed in dogs with OA and HA may be associated with early pathological changes in cartilage damage^[@CR41]^. Intra-articular HA injection for the treatment of cartilage damage has been commonly used, but the efficacy is variable. Armstrong *et al*., observed that the use of intra-articular HA appeared to suppress progression of damage to cartilage and subchondral bone in early OA^[@CR42]^. Clinical variables such as patient global assessment (PGA), walking pain (WP), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) decreased significantly after the injection of HA in a study conducted by Conrozier *et al*.^[@CR43]^. A systematic review comparing corticosteroids with HA in knee articular disease showed that better efficacy was achieved with HA than with corticosteroids over the long term^[@CR44]^. However, other studies hold opposite results. Altman *et al*. found no significant difference between HA and placebo in treating cartilage damage^[@CR45]^. Other studies reported that HA did not change the progression of osteophytosis or fibrosis and did not improve the progression in knee articular disease^[@CR46]--[@CR49]^. This discrepancy might be because of improper injection position^[@CR50]^. In addition, whether the improper or sub-optimal dosage of HA or prolonged interval between induction of cartilage damage and injection of HA could also affect the therapeutics need more evidence to confirm.

We took advantage of HA to promote cell migration^[@CR19]^ and of BMSCs for their chondral differentiation.We found that BMSCs plus HA improved the therapeutic effect for cartilage defect in this study. An improvement in patients treated with allogeneic MSCs compared with HA was confirmed in a study by Vega *et al*.^[@CR30]^. Lamo-Espinosa *et al*. found that BMSCs combined with HA was a safe and available treatment for improvement of knee articular disease in patients^[@CR51]^. In animal models of articular cartilage damage, the efficacy of MSCs combined with HA has been found to be superior to those of MSCs or HA alone^[@CR15],[@CR52],[@CR53]^. In the present study, we found that the macroscopic evaluation scores and histological assessment scale for BMSCs and HA were higher than those for HA alone with statistical significance for both femoral trochlear and condyle defects. Moreover, we also found that the macroscopic and histological scores for trochlear defects were a little higher than those for condylar defects when the same injection treatment was used but no statistical significance existed. The reason for this difference could be that the two defect parts were different on force, and further experiments are required to resolve this discrepancy. Additionally, it was unclear whether the cells improved cartilage repairing directly or whether improvement was caused by nutrition.

There were some limitation in this study that should be considered. First, our experiments were limited to the levels of cells and proteins and lacked of genetic and molecular exploration. Second, the repair of cartilage defects was a dynamic process, and our study was limited to the terminal point of repair. Third, a complex environment existed *in vivo*, and the rationale of MSCs and HA on cartilage repair was not explored. Fourth, this was a preliminary and non-blinded study, which could affect the evaluation of ICRS macroscopic and histological score. Further blinded and basic experiments are needed to improve understanding.

In summary, this study demonstrated that BMSCs plus HA could be a better way to repair cartilage defect in a beagle model. HA alone also contributed to improvement. This finding provides an available approach for the treatment of articular cartilage damage of cartilage defects. Further studies should be conducted that address the study limitation to confirm our findings.

Materials and Methods {#Sec8}
=====================

Animal {#Sec9}
------

This study was approved by the Institutional Animal Care and Use Committee of West China Hospital, Sichuan University, China. Twenty-seven male or female, weighed 5--6 kg at 5--7 months old beagles from the laboratory of Sichuan University were used in this study. All experimental procedures were performed following the guidelines of the care and use of laboratory animals.

Mesenchymal stem cell isolation and cultivation {#Sec10}
-----------------------------------------------

A total of 20 mL bone marrow aspirate mixtures were obtained from 3 male canines (24 canines left for further operation) prior to the transplantation procedure from the ilium. Allogeneic BMSCs were purified by density gradient centrifugation and centrifuged at 2500 rpm for 30 minutes. The cells were washed twice with phosphate-buffered saline (PBS) and resuspended in 10 mL of growth medium a-MEM (10% fetal bovine serum (FBS), 100 mg/mL streptomycin, 100 U/mL penicillin, 2 mmol/L l-glutamine and 25 ng/mL amphotericin B). BMSCs were incubated at 37 °C in a humidified incubator with 5% CO~2~. After 4 days, the culture medium was renewed, the nonadherent cells were removed, and the selected BMSCs were continued in the incubation. The medium was replaced twice a week. After the cultures had reached 70%--80% confluence, they were trypsinized with 0.25% trypsin/0.1% ethylene diamine tetraacetic acid (EDTA) for 3 minutes and passaged. Third-passage cultures (P3) were used in subsequent experiments. Flow cytometry was used to identify cell surface antigen. The P3 BMSCs were digested with 0.25% trypsin/0.1% EDTA and then were collected to give a cell suspension with 2 × 10^5^ cells/mL that was added to different EP tubes. CD29, CD34, CD44, CD45, CD90, CD105 and CD166 were tested by FACS Vantage Flow Cytometry (Beckman, USA). In addition, P3 MSCs cultured to 80% confluence were treated with appropriate media to confirm the multipotential differentiation of osteogenesis and chondrogenesis.

Cartilage defect model and intervention *in vivo* {#Sec11}
-------------------------------------------------

Twenty-four healthy adult canines, male or female with weight ranging from 5.0 to 6.0 kg were used in this study. The canines were forbidden to eat or drink for 6 hours before operation. The canines received anesthesia via intraperitoneal injection with 3% sodium pentobarbital at a dosage of 1 mL/kg. After general disinfection of the knee, we made an incision on the medial knee joint, opened the joint capsule, dislocated the patella laterally and then exposed femoral condyles. Four cartilage defects (1 each for the medial and lateral condyle of the femur, and two for the trochlear groove of the femur) on each canine were created. A corneal trephine with a diameter of 4 mm was used to outline the cartilage defect site. Non-calcified cartilages were scraped away under loupe visualization, but calcified cartilage was not damaged (no bleeding from subchondral bone). The objective of modeling was to remove cartilage as much as possible without damaging the subchondral bone (Fig. [8](#Fig8){ref-type="fig"}). All canines were returned to separate cages after the operations and allowed to move freely. The animals received an antibiotic (800000 U/day penicillin for 3 days) and analgesic (0.12 mg/kg/day buprenorphine for 2 days) after operation. The canines were monitored for signs of activity, movement of joint, local infection, and other complications.Figure 8Operation of cartilage defect model in knee-joint.

Three weeks after the operation, the 24 canines were randomly divided into three groups by injecting different therapeutic substances. We chose the lower and lateral edge of the patella to inject substances and sucked joint fluid back to confirm accurate puncture point. The three groups were as follows: (i) group A (BMSCs plus HA group, n = 8), had 1 × 10^7^ cells and 2 mL 1% HA (pH 6.7, 1000 kDa; Furuida, China) injected into the knee-joints cavity; (ii) group B (HA group, n = 8), had only 2 mL 1% HA injected into knee-joints; (iii) group C (control group with normal saline injected, n = 8).

Gross appearance {#Sec12}
----------------

Twenty-eight weeks after injection, the 24 canines (48 knees) were sacrificed. Surrounding soft tissues were removed and specimens of the defective cartilage were obtained. MRI was conducted to characterise the basic shape or cartilage-like signal at the defect sites. In addition, gross appearance, including the degree of defect repair, integration to border zone, and macroscopic appearance on the surface, were analyzed by two investigators. ICRS macroscopic evaluation of cartilage repair^[@CR54]^ was also used to assess the treatment effect on condylar and trochlear defects. The ICRS macroscopic score was depicted as follows: 12 points indicated normal cartilage, and 0 points indicated severe damage. The higher the score, the better the cartilage repair (Table [1](#Tab1){ref-type="table"}).

Histological analysis {#Sec13}
---------------------

After all samples were washed twice with PBS (pH 7.4, Sigma), they were fixed in 4.0% paraformaldehyde for 7 days at 25--30 °C. And then they were decalcified in 10% formic acid for 3 months. After decalcification, the femoral condyles were cut into three pieces from the lateral to medial condyle along the sagittal plane. All samples were embedded in paraffin and cut into 5-μm sections. Prepared sections were stained with HE staining, Masson staining, and toluidine blue staining. The cell morphology, matrix color, surface intactness, cartilage thickness and integration with adjacent host cartilage were observed.

Immunohistochemical analysis {#Sec14}
----------------------------

The paraffin-embedded tissues were dewaxed by xylene. Type II collagen was retrieved with 1 mg/mL of pepsin (Sigma) in 0.5 M acetic acid at 37 °C for 30 minutes. Endogenous peroxidase was blocked with 3% hydrogen peroxide. The sections were rinsed with PBS and blocked with goat serum (Sichuan University Ltd, China). The sections were incubated with primary antibodies against type II collagen (Anti-Collagen II antibodies, ab34712, Abcam Trading, Shanghai, China) at 4 °C for 12 hours. The secondary antibodies (Peroxidase Affinipure Goat Anti-Mouse IgG (H + L), 115-035-003, Jackson, USA) were incubated at room temperature for 30 minutes as well as peroxidase--conjugated streptavidin (Sichuan University Ltd, China). And then the sections were washed with PBS for 5 minutes three times. Finally, a reagent of 3,3-diaminobenzidine solution containing 0.01% hydrogen peroxide was added and counterstaining was completed with hematoxylin.

Histological score {#Sec15}
------------------

To quantify the differences in histological and immunohistochemical staining, the ICRS Visual Histological Assessment score was evaluated according to the method of Varlet *et al*.^[@CR55]^. In brief, a scale from 18 (good) to 0 (severe) was used to assess condylar and trochlear defects. Surface, matrix, cell distribution, cell population viability, subchondral bone, and cartilage mineralization (calcified cartilage) were assessed (Table [2](#Tab2){ref-type="table"}).

Statistical analysis {#Sec16}
--------------------

The SPSS 22.0 software (SPSS Inc, Chicago, USA) was used for the statistical analyses. All data are reported as means ± SD. Student-Newman-Keuls was performed to compare effects on new cartilage formation among groups. A *P* value \< 0.05 was considered significant.
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